PRGO - PERRIGO Co plc


25.19
-0.030   -0.119%

Share volume: 1,123,469
Last Updated: 04-28-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.10%

PREVIOUS CLOSE
CHG
CHG%

$25.22
-0.03
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 10%
Dept financing 46%
Liquidity 66%
Performance 49%
Company vs Stock growth
vs
Performance
5 Days
1.21%
1 Month
-10.16%
3 Months
2.11%
6 Months
-4.51%
1 Year
-23.22%
2 Year
-32.90%
Key data
Stock price
$25.19
P/E Ratio 
0.00
DAY RANGE
$24.96 - $25.74
EPS 
-$1.33
52 WEEK RANGE
$23.14 - $33.45
52 WEEK CHANGE
-$22.87
MARKET CAP 
3.462 B
YIELD 
4.29%
SHARES OUTSTANDING 
136.415 M
DIVIDEND
$0.29
EX-DIVIDEND DATE
03-07-2025
NEXT EARNINGS DATE
05-06-2025
BETA 
0.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,123,752
AVERAGE 30 VOLUME 
$1,508,276
Company detail
CEO: Murray S. Kessler
Region: US
Website: perrigo.com
Employees: 8,900
IPO year: 1991
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being. The company operates through two segments, Consumer Self-Care Americas and Consumer Self Care International. Its products include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh and Burt's Bees brand names.

Recent news
loading